- Home
- IDN vs ANEB Comparison
IDN vs ANEB Comparison
Compare IDN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- ANEB
- Stock Information
- Founded
- IDN 1994
- ANEB 2020
- Country
- IDN United States
- ANEB United States
- Employees
- IDN N/A
- ANEB N/A
- Industry
- IDN Computer Software: Prepackaged Software
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- IDN Technology
- ANEB Health Care
- Exchange
- IDN Nasdaq
- ANEB Nasdaq
- Market Cap
- IDN 101.6M
- ANEB 111.8M
- IPO Year
- IDN 1999
- ANEB 2021
- Fundamental
- Price
- IDN $4.80
- ANEB $2.77
- Analyst Decision
- IDN Strong Buy
- ANEB Buy
- Analyst Count
- IDN 3
- ANEB 2
- Target Price
- IDN $6.17
- ANEB $8.00
- AVG Volume (30 Days)
- IDN 146.3K
- ANEB 29.2K
- Earning Date
- IDN 11-12-2025
- ANEB 11-12-2025
- Dividend Yield
- IDN N/A
- ANEB N/A
- EPS Growth
- IDN N/A
- ANEB N/A
- EPS
- IDN N/A
- ANEB N/A
- Revenue
- IDN $20,662,000.00
- ANEB N/A
- Revenue This Year
- IDN $9.73
- ANEB N/A
- Revenue Next Year
- IDN $11.75
- ANEB N/A
- P/E Ratio
- IDN N/A
- ANEB N/A
- Revenue Growth
- IDN 7.12
- ANEB N/A
- 52 Week Low
- IDN $2.00
- ANEB $0.80
- 52 Week High
- IDN $6.49
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- IDN 42.57
- ANEB 64.44
- Support Level
- IDN $4.42
- ANEB $2.50
- Resistance Level
- IDN $4.98
- ANEB $2.85
- Average True Range (ATR)
- IDN 0.23
- ANEB 0.15
- MACD
- IDN -0.02
- ANEB 0.04
- Stochastic Oscillator
- IDN 39.21
- ANEB 85.48
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.